IFO50069 Alexander cells
Cell information
Important Notice(s)The Alexander cells: another name of PLC/PRF/5 cell line.
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50069 | Cell Name | Alexander cells |
---|---|---|---|
Profile | hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5). | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 24 |
Identity | available | Tissue for Primary Cancer | liver, gallbladder |
Case history | malignant liver cancer | Metastasis | No |
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | hepatoma, HBs antigen-positive |
Classify | tumor | Established by | Alexander, J. J. |
Registered by | Takeuchi,M. | Regulation for Distribution | |
Comment | Year | 1985 | |
Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | trypsin-EDTA |
Cell Number on Passage | Race | ||
CO2 Conc. | 5 % | Tissue Sampling | liver |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | + | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes | HB virus genome fragment was detected by realtime PCR. However, viral particles were not found (Br. J. Cancer, 34: 509 515 (1976)) in this cell line. In addition, this cell line has not been reported to produce HBV. The infectious HBV particles will not be produced by this cell line. |
Reference | |
---|---|
Pubmed id:63998 | Establishment of a continuously growing cell line from primary carcinoma of the liver. Alexander JJ,Bey EM,Geddes EW,Lecatsas G S Afr Med J. 1976 Dec 18;50(54):2124-8 |
Pubmed id:187208 | Hepatitis B surface antigen produced by a human hepatoma cell line. MacNab GM,Alexander JJ,Lecatsas G,Bey EM,Urbanowicz JM Br J Cancer. 1976 Nov;34(5):509-15 |
Images |
---|
LOT Information
Cell No. | IFO50069 | Cell Name | Alexander cells |
---|---|---|---|
LOT No. | 1011 | Lot Specification | distribution |
Medium | RPMI 1640, 90% ; FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | trypsin-EDTA | |
Doubling Time | Cell Number in Vial (cells/1ml) | 6 x 10^5 | |
Viability at cell freezing (%) | 93 | Antibiotics Used | free |
Passage Number | Unknown (6 at IFO) | PDL | |
Sterility: MYCOPLASMA | + | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type A), MD |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50069 | Cell Name | Alexander cells |
---|---|---|---|
LOT No. | 10252013 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10099). | Temperature | 37C |
Cell Density at Seeding | 3.5 - 4.4 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin and 0.02% EDTA. |
Doubling Time | Cell Number in Vial (cells/1ml) | 1.9 x 10^6 (cells/1 | |
Viability at cell freezing (%) | Antibiotics Used | free | |
Passage Number | Unknown (11 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | G6PD(typeA),NP,LDH were examined. Human |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:12 D13S317:11,12 D7S820:9,11 D16S539:13 VWA:15,16 TH01:7,8 AM:X TPOX:8 CSF1PO:10 |
|
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | 5% | |
Viability immediately after thawing (%) | 89.0 | Additional information |